PharmacoEconomics

Pharmaceutical Care Programmes for the Elderly: Economic Issues
pp. 455-465(11)
Authors: Crealey G.E.; Sturgess I.K.; McElnay J.C.; Hughes C.M.

Cytomegalovirus Infection in Solid Organ Transplantation: Economic Implications
pp. 467-475(9)
Author: Das A.

Measuring the Outcomes and Pharmacoeconomic Consequences of Venous Thromboembolism Prophylaxis in Major Orthopaedic Surgery
pp. 477-496(20)
Authors: Sullivan S.D.; Kahn S.R.; Davidson B.L.; Borris L.; Bossuyt P.; Raskob G.

Using Gross National Product to Calculate Acceptable Immunisation Costs: Deploying Cost-Effectiveness Calculations in Reverse
pp. 497-499(3)
Authors: Tyagi V.; Singh S.K.; Sawhney A.; Taneja V.; Puliyel J.M.

Economic Evaluation of Orlistat in Overweight and Obese Patients with Type 2 Diabetes Mellitus
pp. 501-512(12)
Authors: Maetzel A.; Ruof J.; Covington M.; Wolf A.

A Stochastic Economic Evaluation of Letrozole versus Tamoxifen as a First-Line Hormonal Therapy: For Advanced Breast Cancer in Postmenopausal Patients
pp. 513-525(13)
Authors: Karnon J.; Jones T.